{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:16:17Z","timestamp":1784322977201,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41409-018-0233-2","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T08:35:53Z","timestamp":1528792553000},"page":"85-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hepatic veno-occlusive disease following sirolimus-based immune suppression"],"prefix":"10.1038","volume":"54","author":[{"given":"Farhad","family":"Khimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-2422","authenticated-orcid":false,"given":"Brian","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"233_CR1","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1182\/blood-2014-04-567164","volume":"124","author":"C Cutler","year":"2014","unstructured":"Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, et al. Tacrolimus\/sirolimus vs tacrolimus\/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood. 2014;124:1372\u20137.","journal-title":"Blood"},{"key":"233_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/j.1875-9114.2012.01034.x","volume":"32","author":"PJ Kiel","year":"2012","unstructured":"Kiel PJ, Vargo CA, Patel GP, Rosenbeck LL, Srivastava S. Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation. Pharmacotherapy. 2012;32:441\u20135.","journal-title":"Pharmacotherapy"},{"key":"233_CR3","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","volume":"112","author":"C Cutler","year":"2008","unstructured":"Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, et al. Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood. 2008;112:4425\u201331.","journal-title":"Blood"},{"key":"233_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/01.CIR.0000155612.47040.17","volume":"111","author":"D Fukuda","year":"2005","unstructured":"Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005;111:926\u201331.","journal-title":"Circulation"},{"key":"233_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1096\/fj.01-0658com","volume":"16","author":"R Humar","year":"2002","unstructured":"Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J. 2002;16:771\u201380.","journal-title":"FASEB J"},{"key":"233_CR6","doi-asserted-by":"publisher","first-page":"231S","DOI":"10.1016\/S0041-1345(03)00243-4","volume":"35","author":"AR Marks","year":"2003","unstructured":"Marks AR. Rapamycin: signaling in vascular smooth muscle. Transplant Proc. 2003;35:231S\u20133S.","journal-title":"Transplant Proc"},{"key":"233_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","volume":"19","author":"A Carmona","year":"2013","unstructured":"Carmona A, D\u00edaz-Ricart M, Palomo M, Molina P, Pino M, Rovira M, et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biol Blood Marrow Transplant. 2013;19:1439\u201345.","journal-title":"Biol Blood Marrow Transplant."},{"key":"233_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/bmt.2017.63","volume":"52","author":"F Khimani","year":"2017","unstructured":"Khimani F, Kim J, Chen L, Dean E, Rizk V, Betts B, et al. Predictors of overall survival among patients treated with sirolimus\/tacrolimus vs methotrexate\/tacrolimus for GvHD prevention. Bone Marrow Transplant. 2017;52:1003\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"233_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","volume":"21","author":"KC Myers","year":"2015","unstructured":"Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S. Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:379\u201381.","journal-title":"Biol Blood Marrow Transplant"},{"key":"233_CR10","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301\u20139.","journal-title":"Lancet"},{"key":"233_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3109\/10428194.2012.661052","volume":"53","author":"RK Pai","year":"2012","unstructured":"Pai RK, van Besien K, Hart J, Artz AS, O\u2019Donnell PH. Clinicopathologic features of late-onset veno-occlusive disease\/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant. Leuk Lymphoma. 2012;53:1552\u20137.","journal-title":"Leuk Lymphoma"},{"key":"233_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/0973-1482.59910","volume":"5","author":"MS Shah","year":"2009","unstructured":"Shah MS, Jeevangi NKS, Joshi A, Khattry N. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. J Cancer Res Ther. 2009;5:312\u20134.","journal-title":"J Cancer Res Ther"},{"key":"233_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","volume":"24","author":"HC Toh","year":"1999","unstructured":"Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant. 1999;24:891\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"233_CR14","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","volume":"13","author":"E Carreras","year":"2007","unstructured":"Carreras E, Rosi\u00f1ol L, Terol MJ, Alegre A, de Arriba F, Garc\u00eda-Lara\u00f1a J, et al. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biol Blood Marrow Transplant. 2007;13:1448\u201354.","journal-title":"Biol Blood Marrow Transplant"},{"key":"233_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","volume":"15","author":"U Platzbecker","year":"2009","unstructured":"Platzbecker U, von Bonin M, Goekkurt E, Radke J, Binder M, Kiani A, et al. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant. 2009;15:101\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbmt.2013.04.005","volume":"19","author":"AR Rezvani","year":"2013","unstructured":"Rezvani AR, McCune JS, Storer BE, Batchelder A, Kida A, Deeg HJ, et al. Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes. Biol Blood Marrow Transplant . 2013;19:1033\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"233_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000028359","volume":"60","author":"LD DeLeve","year":"2000","unstructured":"DeLeve LD, Wang X. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology. 2000;60:143\u201354.","journal-title":"Pharmacology"},{"key":"233_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/B978-0-12-387817-5.00008-X","volume-title":"Drug-Induced Liver Disease","author":"LD DeLeve","year":"2013","unstructured":"DeLeve LD. Chapter 8 - Liver Sinusoidal Endothelial Cells and Liver Injury. Drug-Induced Liver Disease. Third edn. Boston: Academic Press; 2013. pp. 135\u201346.","edition":"Third edn"},{"key":"233_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/B978-0-12-387817-5.00031-5","volume-title":"Drug-Induced Liver Disease","author":"A Reuben","year":"2013","unstructured":"Reuben A. Chapter 31 - Hepatotoxicity of Immunosuppressive Drugs. In: Kaplowitz N, DeLeve LD, (eds). Drug-Induced Liver Disease. Third edn. Boston: Academic Press; 2013. pp. 569\u201391.","edition":"Third edn"},{"key":"233_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51:906\u201312.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0233-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:21Z","timestamp":1684617141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0233-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0233-2","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}